molecules Review Enantiomeric Recognition and Separation by Chiral Nanoparticles Ankur Gogoi 1,† , Nirmal Mazumder 2,†, Surajit Konwer 3, Harsh Ranawat 2 , Nai-Tzu Chen 4 and Guan-Yu Zhuo 4,5,* 1 Department of Physics, Jagannath Barooah College, Jorhat, Assam 785001, India;
[email protected] 2 Department of Biophysics, School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India;
[email protected] (N.M.);
[email protected] (H.R.) 3 Department of Chemistry, Dibrugarh University, Dibrugarh, Assam 786004, India;
[email protected] 4 Institute of New Drug Development, China Medical University, No. 91, Hsueh-Shih Rd., Taichung 40402, Taiwan;
[email protected] 5 Integrative Stem Cell Center, China Medical University Hospital, No. 2, Yude Rd., Taichung 40447, Taiwan * Correspondence:
[email protected]; Tel.: +886-4-2205-3366 (ext. 6508); Fax: +886-4-2207-1507 † These authors contributed equally to this work. Academic Editors: Maria Elizabeth Tiritan, Madalena Pinto and Carla Sofia Garcia Fernandes Received: 3 February 2019; Accepted: 10 March 2019; Published: 13 March 2019 Abstract: Chiral molecules are stereoselective with regard to specific biological functions. Enantiomers differ considerably in their physiological reactions with the human body. Safeguarding the quality and safety of drugs requires an efficient analytical platform by which to selectively probe chiral compounds to ensure the extraction of single enantiomers. Asymmetric synthesis is a mature approach to the production of single enantiomers; however, it is poorly suited to mass production and allows for only specific enantioselective reactions. Furthermore, it is too expensive and time-consuming for the evaluation of therapeutic drugs in the early stages of development.